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Results: A total of 48 stents from 24 pigs were harvested. There is no acute in-stent
thrombosis formation during the trial. After 90 days, percent diameter stenosis (%
DS), late loss (LL), and percent area stenosis (%AS) of Ni-Ti sirolimus-eluting
stents was (10.90.3) %, (0.310.02) mm and (23.13.7) %. Histomorphometric
analysis showed no signiﬁcant difference in reducing neointimal hyperplasia
compared to EXCELTM stent in porcine coronary models. No inﬂammatory re-
action was observed around the stent strut of Ni-Ti based stent after 90 days. It
might take 90 days for Ni-Ti sirolimus-eluting stents to complete its re-
endothelialization.
Conclusions: Ni-Tisirolimus-eluting stents with bioabsorbable polymer showed
excellent biocompatibility in porcine model. It is proved that this new DES system
can inhibit neointimal hyperplasia and decrease in-stent stenosis with safety and
efﬁcacy.GW25-e2518
A study of quality of life in patients with coronary heart disease after drug-
eluting stent implantation
Sun Junge, Xiao Jian-Ming
First Afﬁliated Hospital of Kunming Medical University
Objectives: To investigate the quality of life (QOL) after drug-eluting stent (DES)
implantation in patients with coronary heart disease (CHD) and its related factors, so
that we can provide more targeted treatment and guidance for the future of this kind of
patients.
Methods: 132 patients with CHD treated were selected as object of the study.
The patients were voluntary to accept DES implantation for treatment. A ques-
tionnaire survey was conducted before and after drug-eluting stent implantation
for 6 months with SF-36 Questionnaire, Settle Angina Questionnaire (SAQ) and
self-designed basic information questionnaire of patients. The aim is to analyze
the QOL in different gender, age, place of residence, education level and other
risk factors before and after patients with CHD treated with DES and its related
factors.
Results: (1) Scores for physical component summary (PCS), mental component
summary (MCS) and eight categories, Seattle Angina Questionnaire (SAQ) score
and ﬁve categories were better signiﬁcantly after the patients with DES implantation
for 6 months compared with before (all P<0.01). (2) After DES implantation:
The postoperative PF, role-physical (RP), VT, mental health (MH) of patients whose
age <60 years were better than patients whose age 60 years
(86.329.09vs.78.679.55, 69.3626.77vs.51.6719.62, 84.569.12vs.78.7.62,
81.5710.35vs.76.4019.98, all P<0.05); The PF, RP, VT, MH of male patients
were better than female patients (86.329.09vs.78.679.55, 69.3626.77vs
.51.6719.62, 84.569.12vs.78.837.62, 81.5710.35vs.76.4010.98, all P
<0.05). The BP, SF, physical limitation (PL), AS, and AF of patients whose chronic
coronary artery disease (CAD) before operation were better than patients whose
acute coronary syndrome (ACS) (31.4315.42vs.26.9315.66, 60.1216.11vs.
42.6812.09, 39.269.77vs.34.419.03, 34.5214.74vs.24.7717.35, 22.86
8.45vs.9.559.28, all P<0.05), and the difference disappeared after operation.
Patients whose LVEF>50% were better in RP, VT, SF, RE, MH and AS than
those whose LVEF 50% after operation (68.5822.85vs.48.68
34.83,82.968.12vs.74.4712.79, 84.9612.06vs.73.0213.34, 87.9117.85vs.
73.6921.02, 80.219.81vs.71.5812.50, 91.1514.91vs.82.8918.73, all
P<0.05). (3) Age, LVEF, complications, gender and BMI were factors which inﬂect
the QOL after DES implantation for 6 months (PCS: Beta - 0.399, 0.260, -0.256,
-0.229, -0.206, all P<0.05). The patients who had more complications, higher age,
higher BMI, female and lower LVEF had worse QOL.
Conclusions: DES can signiﬁcantly improve the QOL in patients with CHD; The
main factors affected the QOL in patients with CHD were age, gender, BMI, com-
plications, gender and LVEF.GW25-e0055
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Objectives: Arterial stiffness is an independent predictor for vascular diseases. Car-
dio-ankle vascular index (CAVI) is a new index of arterial stiffness. However, there
was little research about the CAVI value between different countries. The aim of the
present study was to compare CAVI between Chinese and Japanese subjects and to
assess related factors.
Methods: 2519 healthy persons [1245 Chinese (M/F, 524/721) and 1274 Japanese
(M/F, 534/740)] from department of physical examination were enrolled into our
study. CAVI was recorded using a VaseraVS-1000 vascular screening system.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/CResults: CAVI was increasing with aging in all subjects. CAVI was signiﬁcantly
lower in Chinese compared with Japanese both in male and female. There was dif-
ference in lipid metabolism between these two groups. Multivariate analysis showed
that age, systolic blood pressure (SBP), fasting plasma glucose (FPG), plasma
creatinine (Cr) were signiﬁcant independent associating factors of CAVI in Chinese
persons (b¼0.548,P<0.001; b¼0.129, P¼0.001; b¼0.105, P¼0.006; and b¼0.100,
P¼0.012, respectively), whereas age, SBP, high density lipoprotein cholesterol (HDL-
C), Cr, body mass index (BMI), FPG were signiﬁcant independent associating factors
of CAVI in Japanese subjects (b¼0.669, P<0.001; b¼0.198, P<0.001; b¼ -0.079,
P<0.001; b¼0.090, P<0.001; b¼ -0.124, P<0.001; b¼0.055, P¼0.009;
respectively).
Conclusions: CAVI was increasing with aging in both Chinese and Japanese subjects.
CAVI was signiﬁcantly lower in Chinese than in Japanese subjects. Age, SBP, FPG
and creatinine were independently associated with CAVI in both Chinese and Japa-
nese subjects.GW25-e0401
Drug-coated balloon versus drug-eluting stent in the treatment of patients
with in-stent restenosis: A meta-analysis of randomized controlled trials
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Objectives: With the development of drug-eluting stent (DES), it has drastically cut
the incidence of in-stent restenosis (ISR). However, the management of DES-ISR is
particularly challenging. Drug-coated balloon (DCB) is a new choice for ISR, and is
an established treatment for ISR after prior bare metal stent and recommended by
present European revascularization guidelines. Several randomized controlled trials
(RCTs) have been developed, but they are compact and the clinical and angiographic
results are not consistent. Thus, we propose to compare the difference of safety and
effectiveness between DCB and DES in the treatment of ISR by the present meta-
analysis of RCTs.
Methods: EMBASE, PubMed, CENTRAL and Google Scholar were compre-
hensively searched in March 2014 for eligible RCTs where patients with
ISR were randomly assigned to either DCB or DES treatment. Endpoints of
interest were all cause death, major adverse cardiac events (MACEs),
target lesion revascularization (TLR), binary restenosis and late lumen loss
(LLL). A ﬁxed-effect model was ﬁrstly utilized to calculate the pooled odds
risk (OR) and standardized mean difference (SMD) with 95% conﬁdence in-
tervals (CIs).
Results: Four studies involving 808 patients were identiﬁed that fulﬁlled the inclusion
criteria in this analysis. Mean follow-up duration was 12 months. For all cause death
(OR 0.809, 95% CI 0.346 to 1.889, P ¼ 0.624, I2 ¼ 27.6%), MACEs (OR 1.033, 95%
CI 0.712 to 1.499, P ¼ 0.863, I2 ¼ 14.6%), TLR (OR 1.320, 95% CI 0.585 to 2.978,
P ¼ 0.504, I2 ¼ 60.5%), binary restenosis (OR 1.012, 95% CI 0.693 to 1.476,
P ¼ 0.951, I2 ¼ 30.9%), and LLL (SMD -0.065, 95% CI -0.315 to 0.185, P ¼ 0.611,
I2 ¼ 67.1%). Among the measurements listed above, TLR and LLL were pooled with
a random-effects model because of heterogeneity. Based on these results, we can
conclude that the outcomes of the comparison between DES and DCB have no sig-
niﬁcant difference.
Conclusions: Being compared to DES, DCB is non-inferior whether on the safety or
effectiveness. Furthermore, DCB use will be polymer-free to reduce the risk of late
thrombosis, decrease the duration of dual antiplatelet therapy and avoid the “onion-
skin” phenomena. Thus, DCB could be considered a promising choice for the treat-
ment of ISR in selected clinical settings.GW25-e0566
Cystatin C combined with creatinine seems to be a reliable early predictor
of MACEs in patients undergoing PCI
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Objectives: Recent studies have demonstrated that serum cystatin C (CyC)
strengthens the association between the eGFR and the risk of death and end-
stage renal disease. Patients with contrast induced-acute kidney injury have
greatly increased risks of cardiovascular events and cardiovascular deaths
after percutanous coronary intervention (PCI), but the prognostic impact of CyC
alone or along with sCr on patients undergoing PCI has not been well
determined.
Methods: We measured CyC together with sCr in 266 consecutive patients under-
going percutaneous coronary intervention (PCI) from June 2013 to February 2014 in
our cardiovascular center. CyC and sCr were assessed at baseline and within 24 to
48 hours after contrast media exposure. Major adverse coronary events (including all-
cause mortality, myocardial infarction, and cardiac revascularization) were assessed
during a mean follow-up of 3.5 months.
Results: Within 24 to 48 hours after contrast media exposure, contrast-induced acute
kidney injury (deﬁned as a sCr increase 25%) occurred in 14 patients (5.26%). A CyCardiovascular Disease Clinical Research C141
increase concentration 10%, 15%, 20% and 25% within 24 to 48 hours after contrast
media exposure was detected in 47 patients (17.67%), 35 patients (13.16%), 24
patients (9.02%) and 16 patients (6.02%), respectively. By logistic regression analysis,
the independent predictor of major adverse events was cutoffs deﬁned as increase in
CyC 10% or sCr 25% (odds ratio3.89; 95% conﬁdence interval, 1.20 to 12.54;
P¼0.02).
Conclusions: In patients undergoing percutaneous coronary intervention,
cystatin C in combined with creatinine seems to be a reliable marker for the early
diagnosis of contrast-induced acute kidney injury, and an independent predictor of
MACEs.GW25-e2330
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Objectives: Endoglin/CD105 is an accessory protein of the transforming growth
factor-b receptor system that plays a critical role in proliferation of endothelial cells
and neovasculature. Here, we aimed to assess the effect of novel stents coated with
antibodies to endoglin (ENDs) on coronary neointima formation.
Methods: Thirty ENDs, thirty CD34 stents (CD34s), thirty sirolimus-eluting stents
(SESs), and thirty bare metal stents (BMSs) were randomly assigned and placed in the
coronary arteries in 40 juvenile pigs. Histomorphometric analysis and scanning
electron microscopy were performed after stent implantation.
Results: Our results showed that after 7 days, there was no difference in the neo-
intimal area and percent area stenosis in ENDs compared with CD34s or SMSs or
BMSs. After 14 days, the neointima area and percent area stenosis in ENDs and
CD34s and SESs were markedly decreased than those in BMSs (P<0.05). Moreover,
the percentage of reendothelialization was signiﬁcantly higher in ENDs and CD34s
than that in SESs or BMSs (P<0.05) at 7 and 14 days. There was no difference in the
neointima area and percent area stenosis and percentage of reendothelialization in
ENDs compared with CD34s. The artery injury and the inﬂammationscores were
similar in all groups at 7 and 14 days.
Conclusions: In conclusion, similar to CD34s,our results demonstrated for the ﬁrst
time to our knowledge that endoglin antibody-coated stents can markedly reduce
restenosis by enhancing reendothelialization in the porcine model and potentially offer
a new approach to prevent restenosis.GW25-e2475
Prvention of contrast-induced Nephropathy with l-carnitine in Coronary
Heart Disease Patients with Diabetes Mellitus undergoing percutaneous
coronary intervention
Li Wenhua, He Haiyan, Wang Lin, Chen Jing, Yu Yaren, Qian Wenhao, Liu Jiali,
Li Dongye
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Objectives: To evaluate the safety and efﬁcacy of l-carnitine in prevention of contrast-
induced nephropathy (CIN) in coronary heart disease (CHD) patients with diabetes
mellitus (DM) undergoing percutaneous coronary intervention and assess the value of
determination of urine kidney injury molecule-1 (KIM-1) protein concentration in the
early diagnosis of CIN.
Methods: A single-center prospective randomized controlled trial was performed,
145 CHD patients with DM were divided randomly into groups control (n¼73,
receiving only 0.9% sodium chloride solution for routine hydration) and
intervention (n¼72, based on routine hydration receiving l-carnitine 3.0 g to join
saline 250 ml of intravenous infusion in 0.9% sodium chloride 3d before opera-
tion, and on day l,2,respectively,after operation).All entrants in surgery on regular
check. The renal function of all patients were accessed before and 1-2 days after
operation. And 15ml urine was collected before and 2h,6h,12h,24h,48h after
operation and centrifuged at 3,000r/min in 4C for 20 minters then 1 ml super-
natant was collected which stored in -80C Ultra-low temperature freezer until
use. Urine KIM-1 level was measured by Enzyme-linked immunosorbent assay
(ELISA).
Results: The two groups were well matched for baseline characteristics, the
average amount of contrast medium during operation. There were 19 cases of
CIN of the 145 patients (13.1%). The incidence of CIN was 19.2% (14/73) in
sodium chloride group while 6.9% (5/72) in l-carnitine group. The incidence of
contrast-induced nephropathy was lower in l-carnitine group than in control, but
the difference was signiﬁcant (6.9% vs 19.2%, P <0.05).There was a signiﬁcant
difference (P <0.05) between the urine KIM-1 level of 2, 6, 12, 24, 48 h
(4015.83855.96, 5095.321235.09, 5982.041506.02, 6984.201441.87,
6078.811519.56) pg/ml after operation and the urine KIM-1 level
(3515.98954.58) pg/ml before operation. There was not a signiﬁcant difference
between the Scr level at 24h after operation and before the operation. CIN can beC142 JACC Vol 64/16/Suppl C j October 16–1diagnosed by urine KIM-1 at least 24h ahead Scr. The area under the ROC curve
of urine KIM-1 24h after operation is 0.856, conﬁdence interval of AUC 95% is
(0.782,0.929). If the critical point of the diagnosis of CIN by the urine KIM-1 is
6327.755pg/ml, the sensitivity is 73.7% and the speciﬁcity is 85.7%. Bivariate
shows that the level of KIM-1 before and 24,48h after operation positively
correlated with Scr at the same time. Binary logistic regression shows: advanced
age, left heart insufﬁciency, high does of contrast agent before operation are the
independent risk facts of CIN.
Conclusions: Short-term application of l-carnitine has the trend of lowering contrast-
induced nephropathy in CHD patients with DM. The results show that urinary KIM-1
levels can be used as an indicator for early diagnosis of CIN.GW25-e2520
The availability of stent enhancement to guide percutaneous coronary
intervention for ostial lesions by stent boost subtract imaging: comparison
with intravascular ultrasound
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Objectives: Percutaneous coronary intervention (PCI) of ostial lesions is complex and
is technically very demanding. Intravascular ultrasound (IVUS) is considered the gold
standard method to guide PCI but has several limitations. Stent Boost Subtract (SBS)
imaging is an enhancement of the radiologic edge of the stent by digital management
of regular X-ray images. The purpose of this study is to determine the availability of
stent enhancement with SBS during ostial PCI by comparison with intravascular
IVUS.
Methods: We investigated SBS and IVUS after stent implantation in 58 ostial lesions
in 55 patients. Ostial lesions included both native aorto-ostial or major coronary vessel
lesions. SBS and IVUS was performed in all patients to obtain improved stent location
and to detect optimal release and deployment.
Results: We deﬁned the SBS and IVUS criteria for adequate stent deployment. IVUS
ﬁndings showed inadequate stent deployment in 10/58 observations (17.2%). Eight
SBS images showed inadequate stent expansion. SBS predicted inadequate ﬁndings of
IVUS with 100% speciﬁcity, 80% sensitivity, meanwhile, a signiﬁcant positive cor-
relation was observed between SBS-MSA and MSA by IVUS with a regression
coefﬁcient of 0.95.
Conclusions: Imaging techniques have a primary role during ostial PCI. SBS is a
simple and quick method that offers several advantages, enabling improved stent
location, adequate stent expansion and optimal apposition of the struts to the wall.
SBS imaging could be conventionally used during ostial PCI, especially in centers
where IVUS is not used routinely.GW25-e3414
Clinical Study of Coronary Artery Lesion in Patients With Angina Pectoris by
Virtual Histology Intravascular Ultrasound
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Objectives: To observe the characteristics of coronary artery lesion in patients with
unstable and stable angina by virtual histology intravascular ultrasound.
Methods: A total of 199 patients with angina pectoris were enrolled in our study, they
were divided into stable angina group (101 cases) and unstable angina pectoris group
(98 cases) according to clinical symptoms, ECG and myocardial enzyme. Coronary
angiography to determine the “criminals” vessels. Comparison of the coronary artery
lesions’ indicators in minimal lumen area measured by grayscale and virtual histology
intravascular ultrasound were made between the unstable angina group and stable
angina group respectively. Grayscale intravascular ultrasound index: external elastic
membrane (EEM), lumen cross-sectional area (LA), plaque area (PA), plaque burden
(PB), remodeling index (RI), plaque eccentricity index (EI) ;Virtual histology intra-
vascular ultrasound index: the plaque composition of calciﬁed tissue, ﬁbrous tissue,
lipid tissue and necrotic tissue.
Results: Two sets of results at the external elastic membrane area, lumen area, plaque
area, eccentricity index, remodeling index have no signiﬁcant difference (t¼1.392,
-.0345, 1.921, 0.378, 0.857, P>0.05). Compared with stable angina group, unstable
angina pectoris group in minimal lumen area have larger external elastic membrane
area, smaller lumen area, greater plaque area, the greater the eccentric index and
remodeling index. Necrotic core (red) area and percentage of lesion composition in
unstable angina group was signiﬁcantly higher than that instable angina group
(t¼2.361, 2.418 P<0.05). Two sets of results at lipid and calciﬁcation area and plaque
distribution percentage have no statistically signiﬁcant differences (t¼1.045, 1.884,
0.787, P>0.05).
Conclusions: Necrotic core area and percentage of plaque composition in the unstable
angina group is larger. “Criminals” lesions are more unstable and more easily
complicated with acute cardiovascular events.9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
